Skip to main content

News

Where hypotheses become headlines: Featured coverage of the breakthroughs—and the people—driving our research forward

For media inquiries, email us: [email protected]


Featured News
Scripps Research scientists train the immune system to make antibodies against numerous HIV strains
News

Scripps Research scientists train the immune system to make antibodies against numerous HIV strains

Joan Pulupa. Credit: Timothy White
News

Joan Pulupa joins Scripps Research faculty to study the organization of DNA in brain cells and its links to neurodegeneration

Filter by:
  • Scripps Research awards doctoral degrees to class of 2021
    News

    Scripps Research awards doctoral degrees to class of 2021

    A total of 42 graduates are earning PhDs after completing their academic journey at the Skaggs Graduate School of Chemical and Biological Sciences.

  • Scripps Research mourns the loss of board member and global health leader John C. Martin
    News

    Scripps Research mourns the loss of board member and global health leader John C. Martin

    Martin, former CEO and executive chairman of Gilead Sciences, made pivotal impacts on global public health over the course of an impressive career spanning science and business.

  • Scripps Research receives inaugural grant from The Conrad Prebys Foundation for scientific research and education
    News

    Scripps Research receives inaugural grant from The Conrad Prebys Foundation for scientific research and education

    A portion of the grant will advance a novel cancer immunotherapy technology at Calibr, the drug discovery and development division of Scripps Research.

  • Scripps Research adds diverse talent to Board of Directors
    News

    Scripps Research adds diverse talent to Board of Directors

    The renowned biochemist JoAnne Stubbe and inventor, businessman and philanthropist Herbert Wertheim are elected to the institute's board.

  • Kenan Trust contributes $1.8 million to science education at Scripps Research, Florida
    News

    Kenan Trust contributes $1.8 million to science education at Scripps Research, Florida

    Scripps Research, Florida has received a $1.8 million philanthropic gift from the William R. Kenan, Jr. Charitable Trust to support science education training.

  • Scripps Research scientists capture 15 spots on ranking of most highly cited researchers
    News

    Scripps Research scientists capture 15 spots on ranking of most highly cited researchers

    The researchers on the 2020 list rank in the top 1 percent of citations in their field over the prior decade, as measured by Web of Science, world’s largest publisher-neutral citation index.

  • 3 Scripps Research scientists win NIH New Innovator Award for ‘high-risk, high-reward’ projects
    News

    3 Scripps Research scientists win NIH New Innovator Award for ‘high-risk, high-reward’ projects

    Assistant Professors Huan Bao, Lisa Racki and Li Ye have been awarded grants through an NIH program that seeks to catalyze scientific discovery by supporting research with transformative potential.   

  • Scripps Research expands Board of Overseers with three esteemed members of the life science community
    News

    Scripps Research expands Board of Overseers with three esteemed members of the life science community

    The Board of Overseers, one of two governing boards at Scripps Research, provides expertise and leadership to advance the institute’s mission.

  • Scripps Research awards doctoral degrees to class of 2020, celebrates graduates’ diverse scientific accomplishments
    News

    Scripps Research awards doctoral degrees to class of 2020, celebrates graduates’ diverse scientific accomplishments

    The Skaggs Graduate School of Chemical and Biological Sciences awarded doctorates to 44 young scientists who comprise the 28th graduating class at Scripps Research. In lieu of the traditional annual commencement ceremony, a virtual celebration will be held in July.

  • FDA approves ozanimod, a drug invented at Scripps Research, for treatment of multiple sclerosis
    News

    FDA approves ozanimod, a drug invented at Scripps Research, for treatment of multiple sclerosis

    The immune-modulating therapy is also in advanced clinical development for adults and children with moderate-to-severe ulcerative colitis and Crohn’s disease. 

  • Scripps Research receives Charity Navigator’s highest rating of four stars
    News

    Scripps Research receives Charity Navigator’s highest rating of four stars

    The rating acknowledges nonprofit organizations and charities that exceed industry standards in financial health, accountability and transparency.

  • Scripps Research mourns the loss of star immunologist and exemplary mentor Wendy L. Havran, PhD
    News

    Scripps Research mourns the loss of star immunologist and exemplary mentor Wendy L. Havran, PhD

    A professor and associate dean, Havran pursued groundbreaking immunology research that revealed key mechanisms of wound healing.

  • Scripps Research spin-off BlackThorn Therapeutics advances lead clinical program for major depressive disorder
    News

    Scripps Research spin-off BlackThorn Therapeutics advances lead clinical program for major depressive disorder

    The clinical-stage biopharmaceutical company BlackThorn Therapeutics, a spin-off from Scripps Research, has begun patient enrollment for a phase 2 clinical trial to evaluate the impact of its lead drug candidate in individuals with major depressive disorder.

  • Iconic actor Alan Alda, Scripps Research join forces to bring science communication training to West Coast
    News

    Iconic actor Alan Alda, Scripps Research join forces to bring science communication training to West Coast

    Alda, the Emmy Award-winning actor, director and writer who has become a leading advocate for effective science communication, has partnered with Scripps Research to bring immersive communication training to scientists.

  • Scripps Research and AbbVie announce collaboration to develop a broad range of new therapeutics
    News

    Scripps Research and AbbVie announce collaboration to develop a broad range of new therapeutics

    A collaboration to develop new therapies for a range of diseases, including oncology, immunology, neurology and fibrosis, is announced with the goal to advance novel medicines to patients.

  • Scripps Research scientists garner 20 spots on annual ranking of world’s highly cited researchers
    News

    Scripps Research scientists garner 20 spots on annual ranking of world’s highly cited researchers

    The prestigious list identifies scientists who’ve disproportionately influenced their fields of research over the past decade.

  • Scripps Research and Shenzhen Bay Laboratory announce international chemical biology research collaboration
    News

    Scripps Research and Shenzhen Bay Laboratory announce international chemical biology research collaboration

    New trans-Pacific chemical biology research collaboration that combines the expertise of both institutions to accelerate the pace of discovery in one of the most promising areas of science.

  • New study reveals Scripps Research, Florida has produced $3 billion worth of economic impact since 2004
    News

    New study reveals Scripps Research, Florida has produced $3 billion worth of economic impact since 2004

    The launch of the Florida campus of Scripps Research has produced an economic impact of $3 billion since the nonprofit biomedical institute opened an East Coast branch 15 years ago. 

  • Scripps Research ranked top U.S. nonprofit scientific institute for second consecutive year
    News

    Scripps Research ranked top U.S. nonprofit scientific institute for second consecutive year

    Scripps Research receives the No. 1 U.S. ranking and No. 5 global ranking in the category encompassing nonprofits and nongovernmental organizations (NGOs).

  • Ambassadors from more than 35 countries visit Scripps Research on State Department tour
    News

    Ambassadors from more than 35 countries visit Scripps Research on State Department tour

    More than 35 ambassadors representing countries across four continents toured Scripps Research to learn more about San Diego’s biomedical research sector.

  • Scripps Research awards doctorates to largest graduating class in institute’s history
    News

    Scripps Research awards doctorates to largest graduating class in institute’s history

    Skaggs Graduate School of Chemical and Biological Sciences recognizes 50+ graduate students, the largest class in the school’s history, on May 17.

  • Scripps Research ranked second in the world among scientific institutes for biomedical research
    News

    Scripps Research ranked second in the world among scientific institutes for biomedical research

    Nature Index has ranked Scripps Research second in the world and first in the United States among stand-alone scientific institutes for biomedical research.

  • Scripps Research spinoff Abide Therapeutics to be acquired by Danish pharma company Lundbeck
    News

    Scripps Research spinoff Abide Therapeutics to be acquired by Danish pharma company Lundbeck

    Abide Therapeutics, Inc., a clinical-stage biopharmaceutical company founded by Scripps Research professors Benjamin Cravatt, PhD, and Dale Boger, PhD, will be acquired by the Danish pharmaceutical firm H. Lundbeck A/S (Lundbeck).

  • Scripps Research selects high school summer interns for 15th annual Kenan Fellows program
    News

    Scripps Research selects high school summer interns for 15th annual Kenan Fellows program

    Eleven students from high schools across Palm Beach County will join biomedical research laboratories at Scripps Research in Jupiter, Florida this summer as part of the institute’s 15th annual high school student internship program.

Groundbreaking Science.
Life-changing Medicine.